The Impact of Sampling on Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy

被引:0
|
作者
Taherian, Mehran [1 ]
Katz, Matthew [1 ]
Prakash, Laura [1 ]
Tong, Yi Tat [1 ]
Lai, Zongshan [1 ]
Chatterjee, Deyali [1 ]
Wang, Hua [1 ]
Kim, Michael [1 ]
Tzeng, Ching-Wei [1 ]
Ikoma, Naruhiko [1 ]
Wolff, Robert A. [1 ]
Zhao, Dan [1 ]
Koay, Eugene [1 ]
Maitra, Anirban [1 ]
Wang, Huamin [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1497
引用
收藏
页码:S1529 / S1530
页数:2
相关论文
共 50 条
  • [1] The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Taherian, Mehran
    Katz, Matthew H. G.
    Prakash, Laura R.
    Wei, Dongguang
    Tong, Yi Tat
    Lai, Zongshan
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei D.
    Ikoma, Naruhiko
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene J.
    Maitra, Anirban
    Wang, Huamin
    CANCERS, 2024, 16 (19)
  • [2] Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Sohn, Aaron J.
    Taherian, Mehran
    Katz, Matthew H. G.
    Prakash, Laura R.
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei D.
    Lee, Jeffrey E.
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene J.
    Sun, Ryan
    Maitra, Anirban
    Wang, Huamin
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2023, 47 (04) : 421 - 430
  • [3] Integrated Pathologic Score Effectively Stratifies Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant therapy and Pancreaticoduodenectomy
    Sohn, Aaron
    Katz, Matthew
    Prakash, Laura
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei
    Lee, Jeffrey
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1233 - 1233
  • [4] Integrated Pathologic Score Effectively Stratifies Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant therapy and Pancreaticoduodenectomy
    Sohn, Aaron
    Katz, Matthew
    Prakash, Laura
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei
    Lee, Jeffrey
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1233 - 1233
  • [5] Tumor Invasion of Muscular Vessels Predicts Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma Who Have Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Chatterjee, Deyali
    Rashid, Asif
    Wang, Hua
    Katz, Matthew H.
    Wolff, Robert A.
    Varadhachary, Gauri R.
    Lee, Jeffrey E.
    Pisters, Peter W.
    Gomez, Henry F.
    Abbruzzese, James L.
    Fleming, Jason B.
    Wang, Huamin
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (04) : 552 - 559
  • [6] The correlation between the proportion of patients with pancreatic ductal adenocarcinoma who received neoadjuvant therapy and overall survival between 2004 and 2015.
    Molina, George
    Chawla, Akhil
    Clancy, Thomas E.
    Wang, Jiping
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [7] Comparative Analyses of the Clinicopathological Features Among Short, Intermediate, and Long Survivors of Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Liang, Tom
    Katz, Matthew
    Prakash, Laura
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei
    Ikoma, Naruhiko
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1514 - S1515
  • [8] Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy
    Christians, Kathleen K.
    Heimler, Jonathan W.
    George, Ben
    Ritch, Paul S.
    Erickson, Beth A.
    Johnston, Fabian
    Tolat, Parag P.
    Foley, William D.
    Evans, Douglas B.
    Tsai, Susan
    SURGERY, 2016, 159 (03) : 893 - 900
  • [9] Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy
    Tong, Yi Tat
    Lai, Zongshan
    Katz, Matthew H. G.
    Prakash, Laura R.
    Wang, Hua
    Chatterjee, Deyali
    Kim, Michael
    Tzeng, Ching-Wei D.
    Lee, Jeffrey E. E.
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene J.
    Maitra, Anirban
    Wang, Huamin
    CANCERS, 2023, 15 (09)
  • [10] Pathologic Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy
    Tong, Yi Tat
    Lai, Zongshan
    Katz, Matthew
    Prakash, Laura
    Wang, Hua
    Chatterjee, Deyali
    Kim, Michael
    Tzeng, Ching-Wei
    Lee, Jeffrey
    Ikoma, Naruhiko
    Rashid, Asif
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1236 - 1236